Neuraxis

NRXS

Market cap $48M

4.51 USD

+0.31

7.38%

At close Updated Dec 30, 4:00 PM EST

Pre-market

After hours

4.51

0.00

1 day

7.38%

5 days

12.19%

1 month

68.91%

3 months

46.43%

6 months

86.36%

Year to date

91.91%

1 year

87.92%

5 years

-24.83%

10 years

-24.83%

About: Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Employees: 21

Healthcare Medical Devices